ION CONTROL OF CARDIAC MUSCLE CONTRACTION: E-C COUPLING
Project Number5R01HL030077-06
Contact PI/Project LeaderBERS, DONALD M
Awardee OrganizationUNIVERSITY OF CALIFORNIA RIVERSIDE
Description
Abstract Text
Our goal is to understand the factors which regulate Ca movements in
cardiac muscle, particularly as they relate to excitation-contraction (E-C)
coupling and the control of cardiac force development. Several techniques
will be used to answer related questions at different levels of Ca
movement. Extracellular Ca microelectrodes will be used to study both the
Ca influx which occurs with each beat (phasic Ca-o depletion) and the net
cellular Ca gains and losses which occur in non-steady-state conditions
(cumulative Ca-o depletion). Intracellular Ca microelectrodes will be used
to study the regulation of intracellular Ca activity (and Ca
compartmentalization). Isolated sarcolemmal vesicles will be used to study
Ca binding and transport activities of the sarcolemma. Changes in
contractile force, dF/dt and action potentials will also be monitored in
most experiments with isolated muscle preparations. The individual
approaches above will provide valuable insights by themselves and the
combination of techniques will increase the depth of conclusions and help
to build a clearer more comprehensive picture of cardiac Ca regulation.
With the central theme of cardiac muscle cellular Ca regulation specific
studies are planned to evaluate: 1) the relative roles of Ca influx and SR
Ca release in the activation of the myofilaments; 2) the role of Na-Ca
exchange in Ca influx (and efflux) in relation to Ca current as well as
Na-H exchange (and Ca efflux routes); 3) the effects of rest duration and
stimulation frequency on Ca influx and cellular Ca loading; 4) the extent
and localization of intracellular Ca (and Na) compartmentalization; 5) the
mechanism of ryanodine action (as compared to caffeine); 6) fundamental
bases for differences in E-C coupling mechanisms in different cardiac
tissues (i.e. rat vs. rabbit); 7) the role of sarcolemmal Ca binding, the
asymmetry of binding and transport sites in physiologically and
pharmacologically induced changes in contractile function; 8) how Ca-i is
handled during anoxic or ischemic incidents. Conclusions to some of these
studies will rely on several of the techniques above. The results of the
planned studies should increase our understanding of the regulation of
basic cardiac muscle function in normal as well as pharmacologically and
pathologically altered states.
No Sub Projects information available for 5R01HL030077-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HL030077-06
Patents
No Patents information available for 5R01HL030077-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HL030077-06
Clinical Studies
No Clinical Studies information available for 5R01HL030077-06
News and More
Related News Releases
No news release information available for 5R01HL030077-06
History
No Historical information available for 5R01HL030077-06
Similar Projects
No Similar Projects information available for 5R01HL030077-06